Mark A. Velleca - PRESIDENT & CEO, Director at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT & CEO, Director
Issuer Symbol
BDTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark A. Velleca since 04 Mar 2025

Holdings reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 121,522 $303,805 $2.50 30 Jan 2025 Direct
Stock Option (Right to Buy) 600,000 21 Jan 2026 Direct Common Stock

Transactions reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.